IP Library Assignment 071814/0792
Patent Assignment
Reel/Frame 071814/0792

Security Interest

Recorded: 2025-07-04 Pages: 13
Assignor
PACIRA PHARMACEUTICALS, INC.
Executed: 2025-07-03
Assignee
WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
P.O. BOX 760776, MAC T7422-012, SAN ANTONIO, TEXAS, 78245
Covered Properties (63)
Sustained Release Formulation of Methotrexate as a Disease-Modifying Antirheumatic Drug (Dmard) and an Anti-Cancer Agent
Patent: 9,770,414 →
Application: 12/914,944 →
Publication: US 2011/0280932
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/283,450 →
Publication: US 2012/0114740
Sustained Release Formulation of Methotrexate as a Disease-Modifying Antirheumatic Drug (Dmard) and an Anti-Cancer Agent
Application: 13/786,323 →
Publication: US 2013/0183370
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,724,302 →
Application: 13/786,378 →
Publication: US 2013/0177635
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Application: 13/786,873 →
Publication: US 2013/0177636
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,737,482 →
Application: 13/786,933 →
Publication: US 2013/0183372
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,757,336 →
Application: 13/786,945 →
Publication: US 2013/0183373
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,737,483 →
Application: 13/787,117 →
Publication: US 2013/0177638
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Patent: 9,974,744 →
Application: 13/787,265 →
Publication: US 2013/0209547
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/787,382 →
Publication: US 2013/0209548
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/787,462 →
Publication: US 2013/0189348
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/787,480 →
Publication: US 2013/0183374
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/790,279 →
Publication: US 2013/0189350
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,808,424 →
Application: 13/791,569 →
Publication: US 2013/0183375
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,730,892 →
Application: 15/249,195 →
Publication: US 2016/0361260
Modifications and Uses of Conotoxin Peptides
Application: 15/525,024 →
Publication: US 2018/0362599
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Application: 15/676,151 →
Publication: US 2018/0092847
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations and Processes for Making the Same
Application: 15/816,916 →
Publication: US 2018/0161275
Conotoxin Peptide Analogs and Uses for the Treatment of Pain and Inflammatory Conditions
Application: 16/734,151 →
Publication: US 2020/0237924
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations and Processes for Making the Same
Application: 16/919,741 →
Publication: US 2020/0397699
Modifications and Uses of Conotoxin Peptides
Application: 17/037,521 →
Publication: US 2021/0122792
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/156,385 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/156,400 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/156,424 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/319,591 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/319,956 →
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations and Processes for Making the Same
Application: 17/344,039 →
Publication: US 2021/0299047
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/536,478 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/536,516 →
Treatment of Hip Pain with Sustained-Release Liposomal Anesthetic Compositions
Application: 17/572,248 →
Publication: US 2022/0218610
Compositions of Bupivacaine Multivesicular Liposomes
Application: 17/590,636 →
Publication: US 2022/0233442
Multivesicular Liposome Formulations of Dexmedetomidine
Application: 17/625,705 →
Publication: US 2022/0273568
Treatment of Hip Pain with Sustained-Release Liposomal Anesthetic Compositions
Application: 17/684,805 →
Publication: US 2022/0218613
Treatment of Pain in Pediatric Patients by Administration of Sustained-Release Liposomal Anesthetic Compositions
Application: 17/697,261 →
Publication: US 2022/0387318
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/719,716 →
Publication: US 2022/0233447
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/720,166 →
Publication: US 2022/0233448
Treatment of Hip Pain with Sustained-Release Liposomal Anesthetic Compositions
Application: 17/746,249 →
Publication: US 2022/0273564
Compositions of Bupivacaine Multivesicular Liposomes
Application: 17/748,933 →
Publication: US 2022/0280426
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/840,104 →
Publication: US 2022/0304932
Treatment of Pain by Administration of Sustained-Release Liposomal Anesthetic Compositions
Application: 17/958,678 →
Publication: US 2023/0042662
Treatment of Pain by Subarachnoid Administration of Sustained-Release Liposomal Anesthetic Compositions
Application: 17/958,780 →
Publication: US 2023/0038098
Multivesicular Liposome Formulations of Dexamethasone
Application: 18/046,312 →
Publication: US 2023/0137783
Bupivacaine Multivesicular Liposome Formulations and Uses Thereof
Application: 18/046,416 →
Publication: US 2023/0133849
Treatment of Post-Operative Pain via Sciatic Nerve Block with Sustained-Release Liposomal Anesthetic Compositions
Application: 18/104,970 →
Treatment of Pain Associated with Total Knee Arthroplasty with Sustained-Release Liposomal Anesthetic Compositions
Application: 18/104,979 →
Publication: US 2024/0148967
Uses of Bupivacaine Multivesicular Liposomes as Stellate Ganglion Block
Application: 18/171,831 →
Publication: US 2023/0277516
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/325,924 →
Publication: US 2023/0293435
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/325,927 →
Publication: US 2023/0301916
Uses of Bupivacaine Multivesicular Liposomes as Stellate Ganglion Block for Treating Anxiety Disorders and Traumatic Brain Injury
Application: 18/503,474 →
Publication: US 2024/0156799
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/761,863 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/761,882 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/761,898 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/762,013 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/762,128 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/809,190 →
Publication: US 2024/0408015
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/943,310 →
Publication: US 2025/0064742
Uses of Bupivacaine Multivesicular Liposomes as Stellate Ganglion Block for Treating Disorders Associated with Sympathetic Nervous System
Application: 18/949,639 →
Publication: US 2025/0161284
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 18/957,404 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 19/002,267 →
Publication: US 2025/0134814
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 19/076,627 →
Publication: US 2025/0352474
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 19/077,685 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 19/209,358 →
Publication: US 2025/0352470
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 90/019,692 →
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Dec 13, 2010
From: PACIRA PHARMACEUTICALS, INC. (A CALIFORNIA CORPORATION); PACIRA PHARMACEUTICALS, INC. (A DELAWARE CORPORATION)
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.; HERCULES TECHNOLOGY III, L.P.
Reel/Frame 025493/0384 →
Assignment of Assignor's Interest Dec 17, 2010
From: GARCIA, LOUIE DANIEL; GIBSON, LOIS; LAMBERT, WILLIAM; LI, BENJAMIN
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 025592/0462 →
Assignment of Assignor's Interest Jan 20, 2012
From: GARCIA, LOUIE DANIEL; ZHU, LIANGJIN; LAMBERT, WILLIAM JOSEPH; PATOU, GARY
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 027571/0834 →
Release of Security Interest May 4, 2012
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.; HERCULES TECHNOLOGY III, L.P.
To: PACIRA PHARMACEUTICALS, INC., A CALIFORNIA CORPORATION; PACIRA PHARMACEUTICALS, INC., A DELAWARE CORPORATION
Reel/Frame 028156/0580 →
Assignment of Assignor's Interest Nov 18, 2015
From: SCHUTT, ERNEST GEORGE; MCGUIRE, RONALD WARREN; WALTERS, PETER ANDREW; LOS, KATHLEEN D.A.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 037077/0554 →
Assignment of Assignor's Interest Mar 1, 2017
From: SCHUTT, ERNEST GEORGE; MCGUIRE, RONALD WARREN; WALTERS, PETER ANDREW; LOS, KATHLEEN D.A.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 041427/0446 →
Assignment of Assignor's Interest Jun 16, 2017
From: SCHUTT, ERNEST GEORGE; MCGUIRE, RONALD WARREN; WALTERS, PETER ANDREW; LOS, KATHLEEN D.A.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 042739/0705 →
Assignment of Assignor's Interest Jan 9, 2018
From: GARCIA, LOUIE DANIEL; ZHU, LIANGJIN; LAMBERT, WILLIAM JOSEPH; PATOU, GARY
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 044575/0248 →
Assignment of Assignor's Interest Jan 10, 2018
From: GARCIA, LOUIE DANIEL; GIBSON, LOIS; LAMBERT, WILLIAM; LI, BENJAMIN
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 044584/0633 →
Assignment of Assignor's Interest Apr 6, 2018
From: POSAKONY, JEFFREY JERARD; MUNOZ, ERNESTO J.
To: KINETA CHRONIC PAIN, LLC
Reel/Frame 045462/0647 →
Assignment of Assignor's Interest Jul 17, 2019
From: SCHUTT, ERNEST GEORGE; MCGUIRE, RONALD WARREN; WALTERS, PETER ANDREW; LOS, KATHLEEN D.A.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 049780/0205 →
Supplemental Confirmatory Grant of Security Interest in United States Patents Dec 14, 2021
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; FLEXION THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058516/0636 →
Confirmatory Grant of Security Interest in United States Patents Mar 31, 2023
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 063214/0108 →
Termination and Release of Security Interest in Patents Mar 31, 2023
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 063213/0864 →
Assignment of Assignor's Interest Feb 7, 2025
From: KINETA CHRONIC PAIN, LLC
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 070152/0871 →
Release of Security Interest Dec 5, 2025
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 073779/0532 →